Nitric oxide synthase responsible for L-arginine-induced relaxation of rat aortic rings in vitro may be an inducible type
- PMID: 1384911
- PMCID: PMC1907878
- DOI: 10.1111/j.1476-5381.1992.tb12752.x
Nitric oxide synthase responsible for L-arginine-induced relaxation of rat aortic rings in vitro may be an inducible type
Abstract
1. Characteristics of L-arginine-induced non-endothelial nitric oxide (NO) formation in rat isolated thoracic aorta were investigated. 2. Relaxation to L-arginine in arterial rings devoid of endothelium developed about 2 h after the first challenge with L-arginine and reached a maximum after a further 4 h of incubation. 3. After the arteries had relaxed in response to L-arginine, guanosine 3':5'-cyclic monophosphate (cyclic GMP) production was stimulated. In fresh arteries that had not yet relaxed in response to L-arginine, L-arginine failed to elevate cyclic GMP levels. 4. Glucocorticoids, actinomycin D and polymyxin B prevented the development of L-arginine-induced relaxation and L-arginine-stimulated increase in cyclic GMP formation. 5. Once L-arginine-induced relaxation developed, these agents no longer suppressed the relaxation and increase in cyclic GMP formation to L-arginine. 6. From these results, it is suggested that in the isolated thoracic aorta of the rat, endotoxin in the medium triggers induction of a non-endothelial NO synthase during prolonged incubation, which accelerates production of NO from added L-arginine to cause relaxation of the arteries via cyclic GMP. Glucocorticoids and protein synthesis inhibitors may prevent induction of NO synthase. It is suggested that the NO synthase mediating the production of muscle-derived NO from L-arginine is an inducible type.
Similar articles
-
Role of endotoxin in L-arginine-induced relaxation of rat thoracic aorta mediated by muscle-derived nitric oxide.Arch Int Pharmacodyn Ther. 1994 Mar-Apr;327(2):152-65. Arch Int Pharmacodyn Ther. 1994. PMID: 7526814
-
Relaxation of rat thoracic aorta induced by the Ca(2+)-ATPase inhibitor, cyclopiazonic acid, possibly through nitric oxide formation.Br J Pharmacol. 1994 Mar;111(3):655-62. doi: 10.1111/j.1476-5381.1994.tb14788.x. Br J Pharmacol. 1994. PMID: 7517325 Free PMC article.
-
L-arginine induces relaxation of rat aorta possibly through non-endothelial nitric oxide formation.Br J Pharmacol. 1991 Apr;102(4):841-6. doi: 10.1111/j.1476-5381.1991.tb12263.x. Br J Pharmacol. 1991. PMID: 1649658 Free PMC article.
-
The nitric oxide/cyclic GMP pathway: a potential major regulator of cochlear physiology.Hear Res. 1998 Apr;118(1-2):168-76. doi: 10.1016/s0378-5955(98)00027-6. Hear Res. 1998. PMID: 9606072 Review.
-
Inhibition of the induction of nitric oxide synthase by glucocorticoids: yet another explanation for their anti-inflammatory effects?Trends Pharmacol Sci. 1991 Apr;12(4):130-1. doi: 10.1016/0165-6147(91)90528-z. Trends Pharmacol Sci. 1991. PMID: 1712139 Review. No abstract available.
Cited by
-
Overnight storage of the porcine isolated splenic artery enhances endothelium-dependent contractions to NG-nitro-L-arginine methyl ester without impairing endothelium-dependent dilator function.Naunyn Schmiedebergs Arch Pharmacol. 1994 Jan;349(1):95-100. doi: 10.1007/BF00178212. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 7511218
-
Vasodilation by intrathecal lipopolysaccharide of the cerebral arteries after subarachnoid haemorrhage in dogs.Acta Neurochir (Wien). 1996;138(3):330-7. doi: 10.1007/BF01411745. Acta Neurochir (Wien). 1996. PMID: 8861703
-
Role of iNOS in the vasodilator responses induced by L-arginine in the middle cerebral artery from normotensive and hypertensive rats.Br J Pharmacol. 1999 Jan;126(1):111-20. doi: 10.1038/sj.bjp.0702281. Br J Pharmacol. 1999. PMID: 10051127 Free PMC article.
-
Inducible nitric oxide synthase and atherosclerosis.Clin Cardiol. 1998 Jul;21(7):473-6. doi: 10.1002/clc.4960210705. Clin Cardiol. 1998. PMID: 9669055 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources